Artigo
Revisado por pares
The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease
2004; Elsevier BV; Volume: 1019; Issue: 1-2 Linguagem: Inglês
10.1016/j.brainres.2004.06.005
ISSN1872-6240
AutoresJohannes Schiefer, Arne Sprünken, Christiane Puls, Hans‐Gerd Lüesse, Anna Milkereit, Eva Milkereit, Verena Johann, Christoph M. Kosinski,
Tópico(s)Neurological disorders and treatments
Referência(s)